Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen
The simultaneous administration of three antiplatelet agents has been proposed as an efficient strategy for the secondary prevention of atherothrombotic events and is included in the European guidelines. However, this strategy presented an increased risk of bleeding; therefore, the identification of...
Main Authors: | Antonios D. Tsiailanis, Constantinos C. Tellis, Paraskevi Papakyriakopoulou, Androniki D. Kostagianni, Vasileios Gkalpinos, Christos M. Chatzigiannis, Nikolaos Kostomitsopoulos, Georgia Valsami, Alexandros D. Tselepis, Andreas G. Tzakos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/5/2311 |
Similar Items
-
Research progress of antithrombotic drugs
by: ZHANG Jie, MA Xuzhou, LI Huihui, WANG Miao
Published: (2023-01-01) -
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
by: Srivastava Padma
Published: (2010-01-01) -
ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01) -
Management of antithrombotic therapy during cardiac implantable device surgery
by: Ahmed AlTurki, MD, et al.
Published: (2016-06-01) -
Gastrointestinal Endoscopy in Patients Receiving Antithrombotic Therapy
by: Supriadi Supriadi, et al.
Published: (2021-09-01)